Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Intarcia
Intarcia
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
BioSpace
Sun, 09/24/23 - 08:52 pm
FDA
ARS Pharmaceuticals
Novartis
Taysha
Alvotech
Intarcia
FDA panel votes against diabetes implant due to safety concerns
Reuters
Fri, 09/22/23 - 11:48 am
Intarcia
diabetes
FDA
ITCA 650
Medtech
Intarcia, a failed diabetes "unicorn," could be resurrected
Axios
Wed, 09/20/23 - 11:17 pm
Intarcia
FDA
diabetes
FDA offers former biotech unicorn Intarcia a chance for a panel review
BioPharma Dive
Thu, 02/9/23 - 06:04 pm
FDA
Intarcia
diabetes
drug-eluting
ITCA 650
Bydureon
Intarcia's speed bump at the FDA turns into a roadblock, as regulators once again turn thumbs down on diabetes drug/device
Endpoints
Tue, 03/10/20 - 11:28 pm
Intarcia
FDA
ITCA 650
diabetes
devices
drug-device combos
Intarcia licenses Numab's autoimmune therapy
BioCentury
Wed, 03/6/19 - 10:04 am
Intarcia
Numab
BD016
type 2 diabetes
[forum discussion] Intarcia employees discuss FDA issues
Cafepharma Message Boards
Sun, 02/4/18 - 11:55 am
Intarcia
layoffs
FDA
Slammed by a trial hold, Intarcia terminates studies and axes staff in wake of an FDA rejection
Endpoints
Sun, 02/4/18 - 11:47 am
Intarcia
clinical trials
layoffs
diabetes
[forum discussion]Intarcia employees discuss life at diabetes startup
Cafepharma Message Boards
Tue, 01/9/18 - 10:07 am
Intarcia
diabetes
FDA accepts Intarcia’s NDA for diabetes drug-device combo
Mass Device
Mon, 02/6/17 - 11:14 am
FDA
Intarcia
diabetes
devices
drug-device combos
Medici
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Fortune
Fri, 05/6/16 - 10:33 am
Intarcia
diabetes
type 2 diabetes
IPOs
ITCA 650
Intarcia nabs GSK castoff Phoundry, beefs up diabetes pipeline
Fierce Biotech
Thu, 09/24/15 - 07:15 pm
Intarcia
GSK
Phoundry Pharmaceuticals
diabetes
M&A
Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?
Fierce Pharma
Fri, 08/28/15 - 05:44 pm
Novo Nordisk
Intarcia
diabetes
ITCA-650
Merck
Januvia
semaglutide
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Bizjournals.com
Tue, 08/18/15 - 09:26 pm
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
Boston's Intarcia now one step closer to upending type 2 diabetes market
Bizjournals.com
Mon, 06/8/15 - 11:23 am
Intarcia
type 2 diabetes
diabetes
ITCA 650
devices
Diabetes upstart Intarcia raffles a slice of future revenue for $225M
Fierce Biotech
Tue, 04/28/15 - 09:52 am
diabetes
Intarcia
devices
Servier Joins Hands With Intarcia Therapeutics To Develop Implantable Diabetic Pump
Bidness Etc.
Thu, 11/13/14 - 12:56 pm
Servier
Intarcia
diabetes
devices
Intarcia's annual diabetes treatment aces two Phase III trials
Fierce Biotech
Thu, 10/2/14 - 10:28 am
Intarcia
diabetes
devices
ITCA 650
Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
First Word Pharma
Tue, 04/1/14 - 03:34 pm
diabetes
Intarcia
exenatide
Intarcia Says It’s in Partner Talks Beyond Diabetes Drugs
Bloomberg
Mon, 01/7/13 - 07:06 pm
Intarcia
diabetes
ITCA 650